* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.
* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.
Von Hippel-Lindau (VHL)-based proteolysis-targeting chimeras (PROTACs) are heterobifunctional degraders that recruit the VHL E3 ubiquitin ligase to a target protein of interest (POI) and trigger its ubiquitination and subsequent proteasomal clearance. As one of the most extensively characterized E3 ligase platforms, VHL offers well-defined binding pockets, mature small-molecule ligand chemotypes, and a strong track record of enabling potent, selective degradation across more than 20 distinct protein targets. BOC Sciences provides integrated VHL-based PROTAC development services spanning ligand design, conjugate engineering, custom synthesis, biophysical and cellular evaluation, and iterative optimization for pharmaceutical, biotechnology, academic, and CRO research teams.
How do VHL-Based PROTACs Work?
A VHL-based PROTAC consists of three functional elements: a VHL-recruiting ligand, a POI-binding warhead, and a linker that controls distance, flexibility, and spatial orientation between the two binding modules. The VHL protein is the substrate recognition subunit of an E3 ubiquitin ligase complex that also contains elongin B, elongin C, cullin 2 (CUL2), and the RING-box protein RBX1. In its native biology, VHL recognizes hydroxylated hypoxia-inducible factor 1α (HIF-1α) and directs it for proteasomal degradation. A PROTAC repurposes this machinery by using a synthetic VHL ligand to recruit the ligase to a non-native POI.
Upon simultaneous engagement of the POI and VHL, the degrader induces formation of a ternary complex. This proximity enables CUL2-RBX1-mediated ubiquitination of the POI, typically at multiple lysine residues. Polyubiquitinated POI is then recognized and degraded by the 26S proteasome. Because a single PROTAC molecule can catalyze multiple turnover cycles, degradation can be achieved at sub-stoichiometric compound concentrations. Productive degradation depends not only on binary binding affinity but also on ternary complex cooperativity, linker geometry, cellular permeability, and the degradation machinery competence of the chosen cell model.
Services
BOC Sciences' Comprehensive VHL-Based PROTAC Development Services
VHL Ligand Design, Synthesis, and Optimization
The VHL ligand defines both recruitment potency and the geometry of the ternary complex. BOC Sciences designs, synthesizes, and optimizes VHL-recruiting building blocks derived from clinically validated chemotypes such as (S,R,S)-AHPC, VH032, and VH298-inspired scaffolds. We evaluate stereochemical requirements, key hydrogen-bonding interactions within the HIF-1α binding pocket, exit-vector positions, and synthetic accessibility to deliver ligands with strong binding and clean derivatization handles.
VHL ligand chemotype selection: assessment of hydroxyproline-based peptidomimetics, alkyl/aryl exit vectors, and polarity to balance binding and cell permeability
Analog and SAR generation: design of analogs that preserve critical VHL contacts while introducing tailored functional handles for linker attachment
Synthetic route development: preparation of VHL ligand intermediates, protected precursors, and click-chemistry-ready building blocks for efficient PROTAC assembly
VHL Ligand-Linker Conjugate Design
The attachment of a linker to the VHL ligand must preserve pocket binding while positioning the POI-warhead for productive ternary complex formation. BOC Sciences designs VHL ligand-linker conjugates with controlled length, flexibility, polarity, and conjugation site, drawing on linker design and optimization expertise to support the spatial orientation required between VHL and the POI.
Exit-vector and attachment-site analysis: identification of positions on the VHL ligand that tolerate modification without disrupting HIF-1α pocket interactions
Linker composition screening: evaluation of PEG, alkyl, rigid aryl, heterocyclic, and cleavable linkers for ternary complex geometry and cell permeability
Conjugate characterization: confirmation of VHL binding retention after linker installation through biophysical and biochemical readouts
Target Protein Ligand Integration and PROTAC Assembly
Building a VHL-based PROTAC requires pairing the VHL recruiter with a POI-warhead that is compatible in size, polarity, and exit-vector orientation. We integrate known warheads or design new POI ligands, then assemble bifunctional degraders using amide, click, or heterocycle-forming chemistry. Our PROTAC design services connect warhead selection, linker scanning, and degradation testing into one coherent workflow.
Warhead sourcing and design: selection or development of POI ligands with suitable binding affinity and derivatizable exit vectors
Bifunctional assembly: convergent synthesis routes that minimize protecting-group complexity and enable rapid analog generation
Library-style generation: preparation of recruiter–linker–warhead matrices to explore degradation space efficiently
Ternary Complex Formation Analysis and Cooperativity Assessment
Degradation is governed by ternary complex stability and cooperativity, not binary binding alone. BOC Sciences applies ternary complex assays to measure whether the PROTAC simultaneously engages VHL and the POI, and to quantify cooperativity (α value) that predicts productive ubiquitination. These data guide linker and warhead redesign before costly cellular work.
Binding and cooperativity measurement: SPR, BLI, TR-FRET, or NMR-based evaluation of ternary complex formation and α cooperativity
Hook-effect assessment: determination of concentration ranges where excess degrader disrupts the ternary complex and reduces degradation
Structural interpretation: integration with docking and mutagenesis data to explain geometry-driven cooperativity differences
VHL-Based PROTAC Degradation Efficiency and Selectivity Profiling
Cellular degradation must be separated from cytotoxicity and nonspecific effects. We use degradation ability assays to quantify DC50, Dmax, and degradation kinetics, and pair them with selectivity evaluation to confirm that the intended POI is depleted without widespread off-target loss. This combination defines whether a candidate is ready for further optimization.
Dose- and time-response profiling: measurement of target loss across concentration and treatment windows to derive DC50 and Dmax
Proteasome-dependence confirmation: rescue with proteasome inhibitors to verify ubiquitin-proteasome-mediated clearance
Selectivity mapping: Western-blot panels and proteomic profiling to distinguish on-target degradation from broader protein loss
Cellular Permeability and Physicochemical Property Optimization
VHL ligands are intrinsically polar and peptidomimetic, making passive cell permeability a recurring bottleneck for VHL-based PROTACs. BOC Sciences applies cellular permeability assays together with property modeling to design degraders that cross membranes while retaining VHL recruitment. We tune linker composition, polarity shielding, and molecular weight to improve intracellular exposure.
Permeability and intracellular exposure: assessment of cellular uptake, efflux liability, and unbound intracellular concentration
Property-driven redesign: adjustment of cLogP, polar surface area, and rotatable bonds to enhance passive diffusion
Solubility and stability: optimization of aqueous solubility and metabolic stability to support reproducible cellular assays
Have You Encountered Following Challenges in VHL-Based PROTAC Development?
Strong VHL binding but weak or no target degradation in cells
Poor passive permeability caused by the polar, peptidomimetic VHL ligand
Unfavorable ternary complex cooperativity or a pronounced hook effect
Degradation activity that collapses across different cell lines or POI isoforms
Off-target degradation of closely related protein family members
Difficulty interpreting whether target loss is degradation or general toxicity
Tell Us Your Challenge
Contact us to discuss how we can help you overcome these hurdles
VHL-based PROTAC projects rarely fail because of a single parameter. Degradation emerges from the interplay of recruiter geometry, linker architecture, warhead orientation, cell permeability, and ternary complex cooperativity. BOC Sciences applies integrated, mechanism-aware solutions that connect molecular design with functional readouts so that optimization decisions are evidence-based rather than trial-and-error.
We generate focused analog matrices that vary the VHL ligand, linker length and composition, and warhead exit vector in a controlled way. Rather than changing one variable blindly, we map degradation outcomes across combinations so that structure–activity relationships become visible early. This approach rapidly identifies which module contributes most to DC50, Dmax, and cooperativity.
Structure-Guided Ternary Complex Modeling
Using available co-crystal structures and molecular dynamics simulation, we model how the PROTAC bridges VHL and the POI. This reveals steric clashes, suboptimal distances, and exit-vector orientations that undermine cooperativity. Modeling informs whether to shorten, lengthen, rigidify, or re-anchor the linker before synthesis.
Iterative Optimization of Potency and Selectivity
We cycle between synthesis, ternary complex assessment, and cellular degradation profiling to push DC50 lower and Dmax higher while monitoring off-target effects. Each iteration narrows the chemical space toward analogs that degrade the intended POI selectively and at tractable concentrations.
Property-Driven Optimization of Cellular Exposure
When degradation fails despite good ternary complex data, the bottleneck is usually permeability or stability. We redesign linkers and shield polar surface area to improve passive diffusion, then confirm intracellular exposure so that cellular degradation reflects true pharmacology rather than compound availability.
Build a VHL PROTAC Program Around Measurable Design Decisions
From VHL ligand chemistry and warhead integration to ternary complex analysis, degradation assays, and property optimization, BOC Sciences provides a coordinated platform for developing VHL-recruiting degraders. Our goal is to identify why each design behaves as it does and convert that understanding into an actionable next synthesis cycle.
VHL-Based PROTAC Assay and Characterization Platform
Target and VHL Binary Binding Assays
Binary binding measurements establish whether conjugation has preserved engagement of the target and VHL. We select fit-for-purpose methods such as surface plasmon resonance, biolayer interferometry, isothermal titration calorimetry, fluorescence polarization, or competition assays. A binding affinity measurement package can provide KD, kinetic, or competitive binding data for parent ligands, intermediates, full PROTACs, and inactive controls.
Ternary Complex Formation and Cooperativity Assays
We quantify target–PROTAC–VHL assembly across concentration ranges and compare ternary behavior with the corresponding binary interactions. Depending on project needs, outputs may include ternary EC50, apparent affinity, cooperativity factor, association and dissociation rates, complex half-life, and hook-effect position. Orthogonal assay formats are recommended when labeling, immobilization, or protein construct choice could bias the result.
Ubiquitination and Proteasome-Dependence Studies
Productive ternary complex formation must lead to target ubiquitination and proteasomal processing. Our protein ubiquitination services can assess target ubiquitin conjugation in reconstituted or cellular systems, while rescue studies with proteasome, neddylation, VHL-binding, or target-binding controls test whether protein loss follows the intended CRL2VHL-dependent mechanism.
DC50, Dmax, and Degradation Kinetics
Concentration-response and time-course experiments define the potency, depth, onset, and durability of degradation. We measure DC50 and Dmax under clearly controlled treatment windows, examine the full concentration range for a hook effect, and compare degradation with target mRNA, cell viability, and loading controls. These data help distinguish direct protein degradation from transcriptional suppression or nonspecific stress.
Protein Recovery and Washout Experiments
Washout studies measure how long protein suppression persists after extracellular compound removal and how rapidly the target is resynthesized. We combine compound washout with target abundance, pathway readouts, and intracellular exposure data to separate sustained degradation from compound retention. Recovery profiles can also reveal whether rapid protein turnover or feedback-driven resynthesis limits the functional duration of a degrader.
Cellular Permeability and Intracellular Exposure Assays
Permeability measurements are interpreted alongside intracellular compound concentration because large bifunctional molecules may show assay-dependent behavior. We can compare passive transport, directional efflux, cell-associated exposure, and target engagement across analogs. This integrated approach identifies compounds that enter cells but are sequestered or expelled and prevents misclassifying exposure-limited molecules as biologically inactive.
Target Selectivity and Proteomic Profiling
Selectivity is evaluated at multiple levels, including target-family immunoblotting, parallel reaction monitoring, targeted panels, and quantitative global proteomics. We compare full PROTACs with parent ligands, inactive VHL epimers, and vehicle controls to identify degradation-specific abundance changes. Concentration and time-course profiling helps distinguish primary degradation events from downstream pathway effects.
Physicochemical and Metabolic Stability Evaluation
We assess solubility, LogD, chemical stability, plasma stability, microsomal or hepatocyte stability, protein binding, and metabolite-forming liabilities according to project stage. PROTAC in vitro metabolism data can be integrated with degradation and exposure results to identify whether linker cleavage, recruiter modification, oxidative metabolism, or nonspecific binding limits useful compound levels.
Workflow
End-to-End VHL-Based PROTAC Development Workflow
01
Project Requirements and Target Biology Review
Understand the POI, disease context, available warheads, cell models, desired degradation depth, and project-stage objectives to define a practical development route.
02
Target and Warhead Feasibility Evaluation
Assess POI ligandability, binding pocket accessibility, isoform complexity, and degradation susceptibility to confirm that a VHL-recruiting strategy is appropriate.
03
VHL Recruitment Strategy Development
Select the VHL ligand chemotype, exit vector, and conjugation chemistry, and define the linker design space based on ternary complex geometry and permeability goals.
04
Molecular Design and Candidate Prioritization
Generate recruiter–linker–warhead matrices, apply docking and molecular dynamics to prioritize candidates, and rank analogs by predicted cooperativity and exposure.
05
PROTAC Synthesis and Analytical Characterization
Execute convergent synthesis through custom PROTAC synthesis, then characterize purity, identity, and integrity using LC-MS, NMR, and HPLC methods.
06
Biophysical and Biochemical Evaluation
Measure binary binding, ternary complex cooperativity, and ubiquitination to confirm mechanism before committing to cellular work.
07
Cellular Degradation and Mechanism Studies
Profile DC50, Dmax, degradation kinetics, proteasome dependence, and selectivity in relevant cell models to establish degradation phenotype.
08
Structure–Degradation Reporting and Recommendations
Deliver integrated data with clear structure–activity interpretation and prioritized recommendations for the next design cycle.
Broad-Spectrum Target Degradation and Resistance Mitigation
VHL recruitment has enabled degradation of kinases, epigenetic readers, transcription factors, and other classes that are difficult to inhibit, and can overcome target mutations that block occupancy-based inhibitors.
Enhanced Selectivity and Reduced Off-Target Effects
Because degradation requires ternary complex formation, VHL PROTACs can achieve selectivity that exceeds the warhead alone by restricting activity to cellular contexts where VHL and the POI coexist.
Catalytic Protein Elimination and High Degradation Efficiency
Event-driven pharmacology allows sustained target loss at sub-stoichiometric concentrations, often with prolonged duration after compound washout compared with reversible inhibitors.
Medicinal Chemistry and Developability Advantages
Mature VHL ligand chemotypes, abundant structural data, and established linker strategies give researchers a well-characterized starting point for rational degrader optimization.
Applications
Applications of VHL-Based PROTAC Technology
Targeting Oncogenic Drivers with VHL-Recruiting Degraders
Degradation of protein kinases and signaling nodes that resist classical inhibition
Exploration of degradation-based strategies for fusion proteins and scaffold-dependent oncoproteins
Comparison with inhibition to assess degradation-specific phenotypic effects
Support for resistance-mechanism studies where target mutation limits occupancy-based drugs
Degrading Transcription Factors and Nuclear Proteins via VHL
Targeted clearance of transcription factors and epigenetic readers with limited druggable pockets
Evaluation of degradation versus inhibition for chromatin-associated targets
Application to BET family proteins such as BRD4 where event-driven loss shows distinct biology
Isoform-selective degradation through warhead and ternary complex tuning
VHL-Based PROTACs for Neurodegenerative Disease Targets
Research support for aggregation-prone and misfolded protein targets in neuronal models
Degradation strategies for proteins implicated in proteinopathy-linked pathways
Client Success Stories in VHL-Based PROTAC Development
Project Background
A biotechnology research team had built a VHL-recruiting PROTAC against a receptor tyrosine kinase involved in solid-tumor signaling. The warhead was a known ATP-competitive binder with sub-micromolar biochemical affinity, and the VHL ligand was a (S,R,S)-AHPC-derived chemotype attached through its standard phenolic exit vector. Despite strong binary binding to both VHL and the kinase in isolated assays, the degrader showed only ~30% target reduction at 10 µM in the client's carcinoma cell line, far below the depth needed for downstream studies. The client suspected the linker was the limiting factor but lacked a systematic way to test it.
Our Support
We first confirmed that both ligands retained binding after conjugation, then turned to the linker as the likely culprit. Using a co-crystal-inspired model of the VHL–kinase ternary complex, we predicted that the original 4-unit PEG linker placed the kinase domain too far from the VHL surface, weakening cooperativity. We designed a 14-member matrix varying linker composition—PEG (2, 4, 6 units), alkyl (C3–C8), semi-rigid trans-cyclohexyl, and rigid phenyl-ether—while keeping the VHL ligand and warhead fixed. Ternary complex TR-FRET screening revealed that a semi-rigid trans-cyclohexyl linker of intermediate length gave the highest α cooperativity, whereas long PEG linkers showed a pronounced hook effect above 3 µM. We advanced six prioritized analogs into cellular degradation assays. The trans-cyclohexyl analog achieved a DC50 of 84 nM with Dmax > 90% at 24 h, while the original PEG linker remained stuck at ~30% even at 10 µM. Washout experiments confirmed sustained target loss for over 24 h, consistent with event-driven degradation. The client received a clear structure–cooperativity map and a single optimized lead ready for further profiling.
Client Testimonial
BOC Sciences turned our vague suspicion about the linker into a quantitative, experiment-backed answer. The ternary complex data explained why our original molecule failed, and the redesigned analog finally gave us the degradation depth we needed.
Project Background
A pharmaceutical discovery group was developing a VHL-based degrader for a bromodomain-containing epigenetic reader expressed across multiple paralogs. Their lead molecule degraded the intended target but also depleted a closely related family member at similar concentrations, undermining the biological question they wanted to answer. The team needed to understand whether the cross-reactivity came from the warhead or from ternary complex geometry, and whether selectivity could be recovered without abandoning the VHL platform.
Our Support
We profiled the lead by global proteomics and found that two paralogs were depleted with DC50 values within two-fold of each other, indicating weak discrimination. Binary binding assays showed the warhead itself preferred the intended target by roughly five-fold, suggesting the ternary complex was the dominant source of cross-reactivity. We built structural models of both paralog ternary complexes and observed that the original alkyl linker allowed the VHL ligand to sample an orientation that accommodated the off-target paralog almost as well as the intended one. We then generated 12 analogs exploring a shorter, more conformationally constrained linker and two alternative VHL exit vectors. Ternary complex cooperativity assays against both paralogs showed that one constrained analog strongly favored the intended complex (α ≈ 6) while showing near-zero cooperativity for the off-target paralog. In cells, this analog degraded the intended reader with a DC50 of 110 nM and Dmax > 85%, while the related paralog was unaffected below 3 µM—a selectivity shift of more than 25-fold. Proteomic profiling confirmed no broader protein loss. The client gained a selectivity-optimized chemical tool and a structural rationale they could apply to future paralog-selective degraders.
Client Testimonial
The BOC Sciences team pinpointed ternary complex geometry as the root cause of our off-target degradation and delivered an analog that finally separated the paralogs. Their proteomic and cooperativity data gave us confidence to move forward.
Why Us
Why Choose BOC Sciences for VHL-Based PROTAC Development?
Specialized VHL Ligand Chemistry Know-How
We understand the hydroxyproline-based VHL ligand space, its stereochemical requirements, and the exit vectors that tolerate modification—so designs start from a strong chemical foundation.
All-in-One Design, Synthesis, and Testing
From VHL ligand and warhead design through linker engineering, synthesis, ternary complex analysis, and cellular degradation profiling, our integrated workflow keeps projects moving without handoff gaps.
Structure-Based Optimization for Better Degraders
We use co-crystal structures, docking, and molecular dynamics to explain cooperativity and guide linker or warhead changes, replacing guesswork with mechanism-aware design.
Proven Strategies to Improve VHL PROTAC Cell Permeability
We address the permeability challenge of polar VHL ligands through linker composition tuning, polarity shielding, and intracellular exposure measurement, improving the odds of cellular activity.
Flexible Collaboration—Pick a Module or the Full Program
Clients can access individual modules, such as VHL ligand design or ternary complex assays, or request end-to-end development from concept to optimized analog series.
Clear Data, Honest Interpretation, Actionable Next Steps
We provide organized experimental data, practical interpretation, and clear recommendations to support the next stage of VHL-based PROTAC design, screening, or validation.
How Do VHL-Based PROTACs Induce Protein Degradation?
A VHL-based proteolysis-targeting chimera (PROTAC) contains a target-binding ligand, a linker, and a VHL-binding ligand. After entering the cell, it brings the target protein into proximity with VHL, the substrate-recognition component of the CRL2VHL E3 ubiquitin ligase complex. Formation of the target–PROTAC–VHL ternary complex positions the target for polyubiquitination. The ubiquitinated protein is subsequently recognized and degraded by the 26S proteasome, while the PROTAC may dissociate and participate in additional degradation cycles.
What Determines Productive VHL Ternary Complex Formation?
Productive ternary complex formation depends on more than the binary affinity of the target ligand or VHL ligand. Linker length, attachment vectors, conformational flexibility, protein–protein contacts, complex stability, and cooperativity collectively determine whether the target is positioned appropriately for ubiquitin transfer. A stable, positively cooperative complex may improve degradation potency and selectivity by favoring productive recruitment over alternative protein orientations. However, the optimal geometry is target-dependent and must be evaluated using structural modeling, biophysical measurements, and cellular degradation data.
How Should VHL PROTAC Linkers Be Optimized?
Linker optimization should evaluate length, composition, rigidity, polarity, exit vectors, and conformational behavior rather than changing chain length alone. A short linker may prevent productive ternary complex formation, whereas an excessively long or flexible linker may increase molecular weight, exposed polarity, and entropic penalties. BOC Sciences designs focused matrices incorporating polyethylene glycol, alkyl, heterocyclic, and semi-rigid linkers. Candidates are prioritized by integrating binary binding, ternary complex formation, DC50, Dmax, permeability, and intracellular exposure results.
Which Assays Confirm VHL-Dependent Degradation Mechanisms?
Mechanism confirmation generally requires concentration- and time-dependent degradation studies, competition with free VHL ligand, an inactive stereoisomer control, pathway-rescue experiments using proteasome or Cullin-RING ligase system inhibitors, target ubiquitination analysis, and washout or protein-recovery measurements. DC50, Dmax, degradation onset, and recovery kinetics should be interpreted together. BOC Sciences uses orthogonal assays to connect target engagement, VHL recruitment, ternary complex formation, ubiquitination, and protein loss while excluding transcriptional suppression, general cellular stress, and nonspecific protein reduction.
What are the most common reasons VHL-based PROTACs fail to degrade?
The most frequent causes are poor ternary complex cooperativity—strong binary binding does not guarantee productive proximity—linker geometry that places the POI surface lysines outside the ubiquitination zone, insufficient cell permeability limiting intracellular exposure, and degradation of only a partial pool of the target due to isoform or compartmentalization barriers. BOC Sciences addresses these through systematic linker scanning, cooperativity measurement, permeability optimization, and mechanistic follow-up to identify and resolve the specific bottleneck in each project.
Quick Inquiry
BOC Sciences Support
Please contact us with any specific requirements and we will get back to you as soon as possible.
We invite you to contact us at or through our contact form above for more information about our services and products.
Broad-Spectrum Target Degradation and Resistance Mitigation
